Skip to main content
Client Work

Neil acted for a Canadian publicly-listed specialist, pharmaceutical company in connection with its acquisition by a publicly-listed international life sciences company in a stock and cash transaction valued at $3 billion.

Fasken
Reading Time 1 minute read
Share
  • LinkedIn

Overview

Client

Confidential Client

Team

  • Neil Kravitz, Partner | Co-lead, Corporate, Co-lead, Cross Border and International Practice, Montréal, QC, +1 514 397 7551, nkravitz@fasken.com